Group 1 - The core viewpoint of the news is the performance and holdings of the ICBC Frontier Medical Stock C fund, which has shown significant returns over various time frames [1] - As of July 23, 2025, the latest net value of the fund is 3.2590 yuan, reflecting a decrease of 0.67% [1] - The fund's one-month return is 9.99%, ranking 348 out of 1027 in its category; the six-month return is 29.58%, ranking 104 out of 995; and the year-to-date return is 26.91%, ranking 122 out of 989 [1] Group 2 - The top ten holdings of the ICBC Frontier Medical Stock C fund account for a total of 59.44%, with significant positions in companies such as Heng Rui Pharmaceutical (9.51%) and Ke Lun Pharmaceutical (9.16%) [1] - The fund was established on November 23, 2020, and as of June 30, 2025, it has a total scale of 1.26 billion yuan [1] - The fund manager is Zhao Bei, who has extensive experience in the healthcare sector and has been managing this fund since February 3, 2016 [2]
7月23日工银前沿医疗股票C净值下跌0.67%，近1个月累计上涨9.99%
Sou Hu Cai Jing·2025-07-23 15:26